Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000491460) titled 'A study of the short-term effects of oral Roxadustat in volunteers over the age of 40' on May 21.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: Royal Perth Hospital
Condition:
Postoperative Complications
Surgical Site Infection
Postoperative Complications
Surgical Site Infection
Surgery - Other surgery
Infection - Other infectious diseases
Intervention:
Three doses of Roxadustat 100mg oral tablets taken on alternate days across a 5-day period i.e. 1x100mg ...